MR1 and neoplasm: Interestingly, the observed T cell reactivity was donor-unrestricted, with multiple HLA-mismatched tumor cells recognized in an MR1-dependent manner, whilst not exerting allo-reactivity, making this T cell clone particularly interesting for immunotherapies (90).